Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? A. Schumacher,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

Helicobacter pylori infection and gastric carcinoma

Outbreak of campylobacter food-poisoning in Northern Ireland

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? A. Schumacher,

Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR I.J. Woolley, M. Larsen,

L. Boyanova Clinical Microbiology and Infection

Helicobacter pylori infection and gastric carcinoma

Outbreak of campylobacter food-poisoning in Northern Ireland

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Atypical respiratory pathogens

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Isospora belli infection in a patient with non-Hodgkin's lymphoma

Vector control: a cornerstone in the malaria elimination campaign

L. Gatta, C. Ricci, A. Tampieri, D. Vaira

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Cephalosporins: a pharmacological update

Laboratory diagnosis and biosafety issues of biological warfare agents

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study J. Zhu,

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Training in infectious diseases and tropical medicine in Britain

Fibronectin concentrations in catheter sepsis

Vaccines for the elderly

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Lymphocyte subset numbers depend on the bacterial origin of sepsis

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity R.J.L.F. Loffeld, C.A.P.M.J.

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? A. Schumacher, I. Seljeflot, A.B. Lerker⊘d, L. Sommervoll, J.E. Otterstad, H. Arnesen Clinical Microbiology and Infection Volume 8, Issue 10, Pages 654-661 (October 2002) DOI: 10.1046/j.1469-0691.2002.00439.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Mean levels of sICAM-1, sVCAM-1 and E-selectin in the CHD patients and their matching healthy controls according to Chlamydia LPS IgA and Helicobacter IgA status. -/-, Chlamydia LPS IgA negative, Helicobacter IgA negative; +/−, Chlamydia LPS IgA positive, Helicobacter IgA negative; +/+, Chlamydia LPS IgA positive, Helicobacter IgA positive; solid bars, CHD patients; stippled bars, matched healthy controls. Clinical Microbiology and Infection 2002 8, 654-661DOI: (10.1046/j.1469-0691.2002.00439.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions